Day: December 10, 2025

Gennvax is advancing its strategic partnership with Kenya’s Ministry of Health, with the completion of a Memorandum of Understanding (MOU) currently in process. This collaboration focuses on enhancing vaccine access, supporting national health priorities, and moving toward self-sufficiency in vaccine production.

In addition to its health initiatives, Gennvax proudly sponsored Kenya’s Ministry of Health National Day on October 6th, supporting environmental sustainability and community engagement. In collaboration with Dr. Mary Muthoni Muriuki, Principal Secretary, State Department for Public Health and Professional Standards, Gennvax planted 200 trees and engaged local schools in campaigns to raise awareness about the environmental and societal benefits of tree planting.

This initiative reflects Gennvax’s broader commitment to:

• Integrating health and environmental responsibility by promoting green initiatives alongside public health programs.

• Community engagement and education, fostering awareness among students and local communities about climate change and sustainable practices.

• Partnership with government and educational institutions to support public health, environmental stewardship, and capacity-building initiatives.

• Long-term impact monitoring, including tracking the growth and survival of planted trees and linking these activities to local health and environmental outcomes.

Through these efforts, Gennvax continues to demonstrate its commitment to sustainable development, health equity, and community empowerment across Kenya and the broader African region.

Gennvax management held a high-level meeting with the Ministry of Science and Innovation of Uganda to discuss strategic collaboration in research and development.

The discussions focused on key partnership pillars, including:

• Upgrading laboratory infrastructure to support cutting-edge vaccine research.

• Conducting clinical trials for next-generation vaccines to ensure high readiness for outbreak response.

• Strengthening quality assurance through technical training and capacity-building initiatives

Gennvax management and team held a high-level meeting with the Ministry of Health of Uganda, including Hon. Margaret Muhanga Mugisa, Minister of State for Primary Health Care, and Hon. Anifa Kawooya Bangirana, Minister of State for Health in charge of General Duties.

During the meeting, both parties agreed to sign a Memorandum of Understanding (MOU) to formalize prospective collaboration. Gennvax also received an official letter of expression of support from the Ministry, marking a significant milestone in their partnership.

The collaboration aims to:

• Facilitate access to vaccines within Gennvax’s portfolio to address Uganda’s national health needs.

• Support technical training and knowledge exchange for Ugandan health professionals.

• Explore opportunities for local capacity building, including technology transfer and infrastructure development.

This initiative reflects Gennvax’s ongoing commitment to enhancing vaccine access, strengthening healthcare systems, and fostering regional collaboration across Africa.

Gennvax, Egypt’s pioneering vaccine manufacturing site, is dedicated to achieving self-sufficiency in core vaccines and contributing to Africa’s health security. In alignment with its vision to locally produce a significant share of the continent’s vaccine needs, Gennvax has embarked on its journey toward market access across Africa.

As a proud member of the Egyptian Vaccines Manufacturers Association (EVMA), Gennvax embraces its role in fostering regional collaboration and strengthening Africa’s biomanufacturing ecosystem. The company’s first destination on this strategic journey was Zimbabwe, where it received full support from Egypt’s Ministry of Foreign Affairs and the Egyptian Ambassador to Zimbabwe.

During a high-level meeting with Zimbabwe’s Ministry of Health and Child Care, Gennvax was honored to sign an Expression of Interest (EOI) with the Honorable Dr. Douglas Mombeshora, Minister of Health.

This agreement marks the beginning of a collaborative partnership aimed at:

• Facilitating access to vaccines within Gennvax’s portfolio to address Zimbabwe’s national health needs.

• Supporting technical training and knowledge exchange for Zimbabwean health professionals.

• Exploring opportunities for local capacity building, including potential technology transfer.

• Strengthening regulatory and quality assurance capabilities in vaccine evaluation and monitoring.

This milestone reflects Gennvax’s commitment to advancing vaccine equity, promoting regional self-reliance, and contributing to a healthier, more resilient Africa.

High-level meeting with Zimbabwe’s Ministry of Health and Child Care, Gennvax was honored to sign an Expression of Interest (EOI) with the Honorable Dr. Douglas Mombeshora, Minister of Health

As part of its commitment to strengthening regulatory partnerships across Africa, Gennvax held a high-level meeting with the Medicines Control Authority of Zimbabwe (MCAZ), represented by Dr. Zivanai Makoni, Head of the Evaluation and Registration Division.
During this strategic meeting, both parties agreed to initiate a pilot program that positions Egypt and Gennvax as the first collaborators to begin the vaccine registration submission process through the newly established MCAZ online platform.
Gennvax has officially received the first access link to commence the upload of its registration and evaluation files — a significant step toward accelerating the availability of quality-assured vaccines in the Zimbabwean market.
This collaboration reflects Gennvax’s ongoing efforts to enhance regulatory cooperation, streamline vaccine registration processes, and reinforce its role as a trusted African manufacturer committed to supporting health security and innovation across the continent.

“The Egyptian Ambassador to Zimbabwe / Hala Serag El Din and the entire embassy team extended their full support to our national project, reflecting the strong spirit of collaboration and shared commitment between Egypt and Zimbabwe toward advancing health and vaccine self-sufficiency across Africa,” said Gennvax representatives.

NAT Pharm Collaborates with Gennvax on Strategic Initiatives NatT Pharm, the leading procurement partner for Zimbabwean health authorities, along with its Managing Director, Newman B. Madzikwa, has formally agreed to collaborate with Gennvax on this strategic initiative. This partnership underscores a shared commitment to enhancing vaccine access, supporting local health systems, and strengthening regional healthcare capabilities.